Stock Market News for August 28, 2026

Capital markets and financing moves

Moderna (MRNA) priced an upsized $2.6 billion convertible senior notes, refreshing liquidity and adding a potential dilution lever investors should watch as management balances R&D funding and long-term capital structure.

Kazia Therapeutics (KZIA) priced a public offering of up to $120 million. For clinical-stage biotech, such raises are critical to extend runways and fund late-stage studies; investors will watch dilution and use of proceeds.

USD.AI / Bullish (BLSH) secured a $100 million stablecoin debt facility to finance GPU purchases, highlighting crypto-linked financing's growing role in capital markets.

N-able (NABL) increased its buyback with a $50 million repurchase boost, a near-term support for EPS and a signal management sees value in the stock.

Earnings, dividends and corporate actions

Best Buy (BBY) announced a regular quarterly cash dividend. For income-focused investors, retailer payouts matter alongside same-store sales and inventory trends.

ENvue Medical (FEED) disclosed a 1-for-12 reverse stock split, a step to regain compliance or consolidate the share base; monitor shareholder dilution and listing status.

Biotech, IP and clinical updates

iBio (IBIO) posted fiscal 2026 results and a corporate update; investors will parse cash runway and R&D spend for partnership or pivot signals. Separately, Aprea Therapeutics (APRE) expanded its intellectual property portfolio around precision oncology programs, which can strengthen valuation ahead of clinical readouts or licensing talks.

Quoin Pharmaceuticals (QNRX) reported positive interim Phase 2/3 data for QRX003 in Netherton syndrome — an event that can re-rate speculation and draw partnership interest.

Agenus (AGEN) announced a peer-reviewed publication tying BOT+BAL’s durable survival in MSS metastatic colorectal cancer to its immune-priming mechanism. Peer-reviewed evidence can de‑risk translational claims and affect partner and investor assessment ahead of further clinical milestones.

Corporate governance and shareholder fights

Better Home & Finance (BETR) saw its special committee urge shareholders to reject former CEO Vishal Garg’s campaign to seize control. Proxy battles heighten governance risk and can drive volatility while votes and litigation unfold.

Netcapital (NCPL) received a Nasdaq notice over a delayed Form 10‑K; such filings are governance red flags and can presage enforcement or remediation steps.

Market moves, partnerships and sector signals

Circle (CRCL) struck a branding deal with Chelsea FC to put USDC in front of global fans — a push for mainstream recognition and trust in stablecoins.

SuperX (SUPX) secured its first batch of 128 NVIDIA B300 AI servers from Ezisight, marking the company's official entry into the Australian market. This commercial win underscores demand for GPU-equipped infrastructure among AI customers and supports revenue visibility for hardware vendors.

BrenX (BRNX) signed a definitive agreement to buy land for an integrated energy resource center in Hungary combining solar, battery and thermal storage and potential data center infrastructure. The move signals how renewables developers are bundling grid assets with compute demand to capture multiple revenue streams.

GreenPower (GP) announced deployment of year two of its New Mexico pilot project, a step that can validate commercial rollout assumptions for electric vehicle and fleet electrification plays.

Corvex (MOVE) appointed Garrett Brams to lead data center infrastructure development, reflecting the ongoing strategic focus on scaling compute capacity and the talent bets companies are making to capture that market.

Insider moves and small-cap activity

Klarna (KLAR) CEO Sebastian Siemiatkowski bought 692,506 shares for ~$10 million. Insider purchases can be confidence signals but should be judged on timing and proportionality.

BioLineRx (BLRX) announced a $3.75 million registered direct offering, a capital move common for pre-revenue biotech to fund near-term milestones.

Listings, rebrands and ticker changes

The Arena Group (AREN) completed a name change to Paradium.AI and will trade under the new ticker PAAI effective August 31, 2026. Rebrands tied to strategic shifts can refocus investor attention but require scrutiny of underlying fundamentals.

How to read today's moves

• Capital raises and convertible issuance (Moderna, Kazia) change dilution and runway assumptions for investors assessing growth versus shareholder dilution.
• Biotech catalysts (Agen, Quoin, Aprea) remain primary re-rating drivers; peer-reviewed data and interim readouts can materially shift risk/reward.
• Commercial and infrastructure wins (SuperX, BrenX, GreenPower, Corvex) highlight how energy and AI compute demand are reshaping capital allocation and partnerships.
• Governance and filings (Better Home, Netcapital) are volatility red flags; proxy fights and late filings deserve attention for potential value transfers or regulatory outcomes.